UroGen Pharma Ltd. (URGN)
Latest URGN Insider Trades
About UroGen Pharma Ltd. (URGN)
UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. The company's flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with Zusduri (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. The revenue source for the company comes from sales of the Company's approved products, Jelmyto and Zusduri, principally conducted in the United States.
- RA'ANANA, L3
- 291
- 2017
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 4 | 85,899 | $3.75M |
| Grant or award | 10 | 112,000 | |
| Option exercise | 4 | 24,000 |
URGN Insider Transactions (Form 4)
1639 Form 4 filings on record, the earliest from Oct 9, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| James A. Robinson Jr. - Director | Grant or award | Stock Option (right ot buy) | 10,000 |
Recent URGN Form 8-K Filings
5Recent URGN Form 144 Notices of Proposed Sale
3A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Schoenberg Mark | Officer | 60,677 | $2.89M | View on EDGAR | |
| - | - |
URGN Insider Trading - FAQ
What is the latest insider trade for URGN?
UroGen Pharma Ltd. (URGN) had 11 insider filings in the last 90 days, with the most recent on 2026-08-28. The full record for URGN runs to 39 Form 4 filings, the earliest from 2024-10-09. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying URGN stock?
No insider purchases of URGN were filed in the last 90 days.
How many insiders are selling URGN stock?
4 insider sales of URGN were filed in the last 90 days, totaling $3.75M.
Where can I see URGN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks URGN Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow URGN insider buys?
Create a free InsiderAlpha account and press Watch on this page to add URGN to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - James A. Robinson Jr. view on EDGAR
- - Mark Schoenberg view on EDGAR
- - Mark Schoenberg view on EDGAR
- - Mark Schoenberg view on EDGAR
- - Daniel George Wildman view on EDGAR
- - James A. Robinson Jr. view on EDGAR
- - Stuart Holden view on EDGAR
- - Cynthia M. Butitta view on EDGAR
- - Leana Wen view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where URGN's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track URGN insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
